IMBROGNO EDWARD (VP, Finance and CAO) reported 1 transaction at PDL BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/7/2020ACC: 0000882104-20-000043
Officer· VP, Finance and CAO
Since Jun 2019
-82.49K
Net shares
Net seller
$289.5K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
82.49K disposed
Non-Derivative Transactions1
Common stock
Direct
Shares
−82.49K
Price / share
$3.51
Trade value
$289.53K
% of position
26.2%
2/7/2020
314.56K→232.08K
Total
Net shares
−82.49K
Net value
-$289.53K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 2/7/2020 | F · Tax Withholding | −82.49K | $3.51 | $289.53K | 26.2% | 314.56K | 232.08K |
| Total | −82.49K | -$289.53K | ||||||
Derivative Transactions0
No derivative transactions reported